Laurence Matthew Skelton
CIK: 0002108080
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VERA
Vera Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Skelton Laurence Matthew
Skelton Laurence Matthew (SEC CIK 0002108080) files insider reports with the SEC as Chief Commercial Officer of Vera Therapeutics, Inc. (VERA).
Signal8 holds 3 ownership filings by Skelton Laurence Matthew (1 Form 3, 2 Form 4), filed between Jan 30, 2026 and Feb 25, 2026. Those filings report 2 transactions, from Feb 4, 2026 to Feb 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Skelton Laurence Matthew's filings is in BRISBANE, CA.
Recent filings by Skelton Laurence Matthew
Other insiders filing for Vera Therapeutics, Inc. (VERA)
- Fordyce Marshall, PRESIDENT AND CEO
- Young Joseph R, SVP, FINANCE, CHIEF ACCT OFFCR
- Boman Nancy Lee, Chief Regulatory Officer
- Morrison Scott W, Director
- Cheng Andrew, Director
- SEIDENBERG BETH C, Director